人类晶状体蛋白变异与白内障
本文综述了α、β、γ晶状体蛋白基因突变导致白内障的致病机制。晶状体蛋白占晶状体总蛋白90%以上,α晶状体蛋白作为小热休克蛋白具有分子伴侣活性,β和γ晶状体蛋白主要维持结构。不同晶状体蛋白突变通过扰动蛋白稳定性、相互作用和溶解度,促进错误折叠、聚集或异常相行为,破坏晶状体蛋白稳态,增加光散射,最终导致晶状体混浊。人工智能辅助方法有望进一步细化白内障表型和分子变异的解读。
要点
- 晶状体蛋白占晶状体总蛋白90%以上,对维持晶状体透明和长期蛋白稳态不可或缺。
- α晶状体蛋白具有分子伴侣活性,β和γ晶状体蛋白主要起结构作用。
- 不同晶状体蛋白突变汇聚于共同致病机制:蛋白错误折叠、聚集和溶解度改变。
核心结论
- α、β、γ晶状体蛋白基因突变通过扰动蛋白稳定性、相互作用和溶解度,促进错误折叠、聚集或异常相行为,破坏晶状体蛋白稳态,增加光散射,最终导致晶状体混浊。
- 人工智能辅助方法可能在未来研究中进一步支持疾病表型和分子变异的解读。
研究设计与样本
- 综述类文章,检索范围未在摘要中报告。
主要发现
- 晶状体蛋白占晶状体总蛋白90%以上,对维持晶状体透明和长期蛋白稳态不可或缺。
- α晶状体蛋白作为小热休克蛋白具有分子伴侣活性,β和γ晶状体蛋白主要起结构作用,具有保守的Greek-key基序以支持致密蛋白堆积和适当折射特性。
- α、β、γ晶状体蛋白突变汇聚于共同致病机制,包括扰动蛋白稳定性、分子间相互作用和溶解度,促进蛋白错误折叠、聚集或异常相行为。
- 上述改变破坏晶状体蛋白稳态,增加光散射,最终导致晶状体混浊。
- 白内障相关成像和遗传数据正日益采用新兴计算方法分析,人工智能是快速发展的方向。
临床怎么用
- 对于白内障患者,尤其是儿童白内障,应考虑晶状体蛋白基因突变作为病因。
- 理解晶状体蛋白突变的共同致病机制有助于解释白内障表型和分子变异。
- 人工智能辅助方法可能在未来帮助细化白内障的机制解读和分子特征分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cataract is a leading cause of reversible childhood blindness worldwide and is largely attributable to mutations in crystallin-encoding genes of the α-, β-, and γ-crystallin families. Crystallins account for over 90% of total lens proteins and are indispensable for maintaining lens transparency and long-term proteostasis. These three crystallin families display distinct structural organizations and functional specializations: α-crystallins function as small heat shock proteins (sHSPs) with molecular chaperone activity, whereas β- and γ-crystallins serve primarily structural roles, characterized by conserved Greek-key motifs that support dense protein packing and appropriate refractive properties of the lens. Despite these differences, mutations across α-, β-, and γ-crystallins converge on common pathogenic mechanisms by perturbing protein stability, intermolecular interactions, and solubility, thereby promoting protein misfolding, aggregation, or aberrant phase behavior. Such alterations disrupt lens protein homeostasis, increase light scattering, and ultimately lead to lens opacification. Cataract-related imaging and genetic data are increasingly being analyzed using emerging computational approaches, among which artificial intelligence (AI) represents a rapidly developing direction that may further support the interpretation of disease phenotypes and molecular variants in future studies. In this review, we synthesize current knowledge on human crystallin variation, pathogenic mechanisms of crystallin gene mutations, and cataract phenotypes, and discuss how AI-assisted approaches may further refine mechanistic interpretation and molecular characterization of cataract.
引用
- Ma M, Zhang X, Li Y, et al. Human Crystallin Variation and Cataract. Invest Ophthalmol Vis Sci. 2026. PMID: 42370641. doi:10.1167/iovs.67.6.55
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。